Why the study?
Voltage-gated potassium channels influence plasma membrane potential, cell volume, and potassium concentration, which affect cell cycle progression, proliferation, and apoptosis.
Voltage-gated potassium channels are critical regulators of cell proliferation and apoptosis, presenting potential pharmacological targets for cancer therapy.
Hypothesis-generating for potassium channel-targeted cancer therapies; leaves open clinical adoption without dedicated trials.
Ion channels allow the flux of specific ions across biological membranes, thereby determining ion homeostasis within the cells. Voltage-gated potassium-selective ion channels crucially contribute to the setting of the plasma membrane potential, to volume regulation and to the physiologically relevant modulation of intracellular potassium concentration. In turn, these factors affect cell cycle progression, proliferation and apoptosis. The present review summarizes our current knowledge about the involvement of various voltage-gated channels of the Kv family in the above processes and discusses the possibility of their pharmacological targeting in the context of cancer with special emphasis on Kv1.1, Kv1.3, Kv1.5, Kv2.1, Kv10.1, and Kv11.1.
No takes yet. Share an insight, caveat, or question.
Bachmann et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: